Showing results (841-850 of 1,135) with videos related to
Sort By:
Pageof 114
Journal of Dairy Science|February 23, 2024
Effects of a multistrain Bacillus-based direct-fed microbial on gastrointestinal permeability and biomarkers of inflammation during and following feed restriction in mid-lactation Holstein cowsB M Goetz, M A Abeyta, S Rodriguez-Jimenez, et al.The Journal of Allergy and Clinical Immunology|April 22, 2003
Evidence for gene-environment interactions in a linkage study of asthma and smoking exposureSusan Colilla, Dan Nicolae, Anna Pluzhnikov, et al.Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapyN M Ferguson, F deWolf, A C Ghani, et al.Gastroenterology|May 1, 1994
Ursodeoxycholic acid in the treatment of primary biliary cirrhosisK D Lindor, E R Dickson, W P Baldus, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2006
Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countriesPapa S Sow, Leander F Otieno, Emmanuel Bissagnene, et al.AIDS (London, England)|August 10, 2000
A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patientsK Ruxrungtham, E D Kroon, C Ungsedhapand, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 3, 2025
Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: a systematic review and meta-analysisYolba Smit, Pien Scheuter, Myrthe P M Lange, et al.Lancet (London, England)|July 26, 1986
Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infectionJ Goudsmit, F de Wolf, D A Paul, et al.AIDS (London, England)|March 14, 2000
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM studyM H Reijers, H M Weigel, A A Hart, et al.Sexually Transmitted Infections|January 30, 1999
Lack of efficacy of low dose oral interferon alfa in symptomatic HIV-1 infection: a randomised, double blind, placebo controlled trialE T Katabira, N K Sewankambo, R D Mugerwa, et al.Pageof 114